PressWatch Posted April 7, 2011 Posted April 7, 2011 From PresswatchThis is evidence to support the case for a substance known as VEGF as representing a significant and reproducible marker for the sadly adverse indication in resected (ie surgically removed ) Pancreatic Cancer.It is a literature review and statistical analysis of existing data conducted by a team including Prof John Neoptholemous ( Liverpool) who is generously providing valuable information and support to the PCUK funded 'Study for Survival' (http://www.pancreaticcancer.org.uk/study_survival_home.htm ) Smith RA, Tang J, Tudur-Smith C, Neoptolemos JP, Ghaneh P. Related Articles Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer. 2011 Mar 29;. [Epub ahead of print] PMID: 21448172 [PubMed - as supplied by publisher]Includes VEGF, p53, p16,Smad4,bcl.bax, EGFR
Recommended Posts